- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03881436
Assessment of MRI Tractography for Pelvic Floor Sphincter Analysis (TractoCA)
Urinary and faecal incontinences generally come from a dysfunction of the pelvic floor muscles, and more particularly the sphincters. Among other causes, they may be related to accidental trauma, obstetric or iatrogenic. On this last point, the incidence of surgical interventions on the bladder collar and on the anal canal on the prevalence of incontinences can be underlined.
MRI tractography could be an interesting tool to visualize in 3D the structure of pelvic sphincters and their lesions. It may thereby establish the link with observed dysfunctions, thus potentially providing a complement to the urological and proctographic examinations already carried out.
The objective of this study is, first, to define the sensitivity of the MRI tractography for the visualization of the pelvic sphincters architecture regardless of the gender. In a second time, it will give a description of normal and abnormal (pathological cases) tractography, as well as a descriptive post-surgery. The other interest of this study is the assessment of the information provided by pelvic sphincters tractography on a panel of various and frequently encountered situations in clinical routine at the IHU.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Urinary and faecal incontinences are psychologically difficult to live with. These disorders generally come from a dysfunction of the pelvic floor muscles, and more particularly the sphincters: the urethral sphincter at the level of the urinary tract, and the anal sphincter at the level of the defecatory apparatus. The causes leading to urinary or faecal incontinence are multiple. They may be related to age or weight, or to accidental trauma, obstetric or iatrogenic. On this last point, the incidence of surgical interventions on the bladder collar and on the anal canal on the prevalence of incontinences can be underlined.
In case of dysfunction, the sphincters can be scanned by imaging, including MRI, to assess the thickness or detect the presence of scars. The current MRI examinations in clinical routine are not capable to characterize the complex architecture of these muscles. MRI tractography, mainly known as a tool for visualisation and characterisation of white matter fibers in the brain via the acquisition of DTI (Diffusion Tensor Imaging) sequences, could be an interesting tool to visualize in 3D the structure of pelvic sphincters and their lesions. It may thereby establish the link with observed dysfunctions, thus potentially providing a complement to the urological and proctographic examinations already carried out.
Some studies have already shown that MRI is an ideal method for visualizing pelvic floor muscle fibers in women. As far as it is known, there are no studies in the literature on pelvic sphincter tractography. The objective is, first, to define from this initial study the sensitivity of the method for the visualization of the pelvic sphincters architecture regardless of the gender. In a second time, it will give a description of normal and abnormal (pathological cases) tractography, as well as a descriptive post-surgery. The results found in each of these situations can be compared in order to evaluate the sensitivity and contribution of MRI tractography for the diagnosis of pelvic sphincter dysfunctions and their management, as well as to evaluate the impact of surgery.
The other interest of this study is the inclusion of both patients consulting for a simple diagnosis and those coming for a pre- and post-operative examination. This will allow the assessment of the information provided by pelvic sphincters tractography on a panel of various and frequently encountered situations in clinical routine at the IHU.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Strasbourg, France, 67 091
- Service de Radiologie et d'Echographie, NHC Strasbourg
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Male or female over 18 years old
- Patient able to receive and understand information related to the study and give written informed consent
- Patient affiliated to the French social security system
- Patient undergoing a pelvic MRI examination whose result at the end of the T2 sequences in the 3 section planes shows the absence of pathology or a distant pathology that does not affect the pelvic sphincters OR Patient undergoing a pelvic surgery including fistula treatment, abscess treatment, sigmoid mucosectomy or rectal mucosectomy
Exclusion Criteria:
- Patient who previously had a therapeutic procedure affecting the sphincters
- Patient with hip prostheses
Patient with contraindications to MRI:
- pacemaker or automatic defibrillator, pump
- implanted
- auditory, anal, painkiller neurostimulator, etc ...
- ferromagnetic bodies in soft tissues, body
- intraocular foreigners, cerebrovascular clips
- claustrophobia
- Patient presenting, in the judgment of the investigator, an illness that may prevent participation in the procedures provided by the study
- Pregnant or lactating patient
- Patient in exclusion period (determined by a previous or a current study)
- Patient under guardianship or trusteeship
- Patient under the protection of justice
Study Plan
How is the study designed?
Design Details
- Primary Purpose: DIAGNOSTIC
- Allocation: NON_RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Pelvic MRI
This arm involves patients undergoing a pelvic MRI. At the end of the planned sequence, but before any contrast agent injection:
|
At the end of the planned sequence, but before any contrast agent injection:
|
|
EXPERIMENTAL: Pelvic surgery
This arm involves patients undergoing a pelvic surgery and coming for a postoperative MRI. An additional MRI is performed before the surgery and additional sequences are added to the planned postoperative MRI, at the end of the planned sequence, but before any contrast agent injection:
|
At the end of the planned sequence, but before any contrast agent injection:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The ability of MRI tractography to visualize the muscular architecture of pelvic sphincters evaluated with a Likert score.
Time Frame: 1 day for the "Pelvic MRI" group - 2 months for the "Pelvic surgery" group
|
This criterion is quantitative and is evaluated on the basis of a Likert score varying between 1 and 5 which will be attributed to each sphincter.
|
1 day for the "Pelvic MRI" group - 2 months for the "Pelvic surgery" group
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Evaluation of the sphincter orientation based on a color gradient.
Time Frame: 1 day for the "Pelvic MRI" group - 2 months for the "Pelvic surgery" group
|
The reconstruction of the muscle fibers in tractography is done according to a precise color code (blue if orientation up-down, green for front-back, and red for left-right). The analysis will be done on the color gradient. |
1 day for the "Pelvic MRI" group - 2 months for the "Pelvic surgery" group
|
|
Thickness of the sphincters evaluated in millimetres
Time Frame: 1 day for the "Pelvic MRI" group - 2 months for the "Pelvic surgery" group
|
The thickness of the sphincters will be measured in millimetres
|
1 day for the "Pelvic MRI" group - 2 months for the "Pelvic surgery" group
|
|
Fractional Anisotropy (FA) Values in Sphincter Fibres
Time Frame: 1 day for the "Pelvic MRI" group - 2 months for the "Pelvic surgery" group
|
Fractional anisotropy (FA) is a scalar value between zero and one that describes the degree of anisotropy of a diffusion process.
A value of zero means that diffusion is isotropic, i.e. it is unrestricted (or equally restricted) in all directions.
A value of one means that diffusion occurs only along one axis and is fully restricted along all other directions.
|
1 day for the "Pelvic MRI" group - 2 months for the "Pelvic surgery" group
|
|
Apparent Diffusion Coefficient (ADC) Values in Sphincter Fibres
Time Frame: 1 day for the "Pelvic MRI" group - 2 months for the "Pelvic surgery" group
|
Apparent diffusion coefficient (ADC) is a measure of the magnitude of diffusion (of water molecules) expressed in units of square millimetres per second (mm2/s).
|
1 day for the "Pelvic MRI" group - 2 months for the "Pelvic surgery" group
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Catherine ROY, MD, Service de Radiologie et d'Echographie, NHC Strasbourg
Publications and helpful links
General Publications
- Zijta FM, Froeling M, van der Paardt MP, Lakeman MM, Bipat S, van Swijndregt AD, Strijkers GJ, Nederveen AJ, Stoker J. Feasibility of diffusion tensor imaging (DTI) with fibre tractography of the normal female pelvic floor. Eur Radiol. 2011 Jun;21(6):1243-9. doi: 10.1007/s00330-010-2044-8. Epub 2011 Jan 1.
- Zijta FM, Lakeman MM, Froeling M, van der Paardt MP, Borstlap CS, Bipat S, Montauban van Swijndregt AD, Strijkers GJ, Roovers JP, Nederveen AJ, Stoker J. Evaluation of the female pelvic floor in pelvic organ prolapse using 3.0-Tesla diffusion tensor imaging and fibre tractography. Eur Radiol. 2012 Dec;22(12):2806-13. doi: 10.1007/s00330-012-2548-5. Epub 2012 Jul 14.
- Rousset P, Delmas V, Buy JN, Rahmouni A, Vadrot D, Deux JF. In vivo visualization of the levator ani muscle subdivisions using MR fiber tractography with diffusion tensor imaging. J Anat. 2012 Sep;221(3):221-8. doi: 10.1111/j.1469-7580.2012.01538.x. Epub 2012 Jul 4.
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 18-005
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Inflammatory Bowel Disease
-
Cook Children's Health Care SystemNot yet recruitingIBD | IBD - Inflammatory Bowel Disease | IBD (Inflammatory Bowel Disease)United States
-
Ningbo Medical Center Lihuili HospitalRecruitingInflammatory Bowel Disease (IBD)China
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaRecruitingIBD - Inflammatory Bowel DiseaseItaly
-
Chang Kyun LeeChonnam National University Hospital; Kyungpook National University Hospital; Chung-Ang University Hosptial, Chung-Ang University College of Medicine and other collaboratorsRecruitingInflammatory Bowel Disease (IBD)Korea, Republic of
-
Centre Hospitalier Universitaire, AmiensFunding from DGOS (PHRC IR 2013 and PRME)CompletedPediatric Inflammatory Bowel DiseaseFrance
-
Assiut UniversityNot yet recruitingInflammatory Bowel Disease (IBD)
-
University of British ColumbiaCompletedInflammatory Bowel Disease 11Canada
-
University of ChicagoTerminatedInflammatory Bowel Disease (IBD)United States
-
University Hospital, GrenobleInstitute for Advanced Biosciences (IAB), GrenobleNot yet recruitingInflammatory Bowel Disease (IBD)France
-
The Second Hospital of Nanjing Medical UniversityNot yet recruiting
Clinical Trials on MRI with DTI sequence
-
Lille Catholic UniversityRecruitingMagnetic Resonance Imaging | Lumbar Radiculopathy | Diffusion Tensor ImagingFrance
-
Memorial Sloan Kettering Cancer CenterCompleted
-
Memorial Sloan Kettering Cancer CenterCompletedHead and Neck Cancer | Prostate CancerUnited States
-
Poitiers University HospitalCompleted
-
Central Hospital, Nancy, FranceNot yet recruitingHealthy | Temporomandibular Joint DisordersFrance
-
Centre Hospitalier St AnneGeneral ElectricCompletedCerebro-vascular DiseaseFrance
-
University Hospital MuensterUnknownClinically Isolated Syndrome, CNS Demyelinating | Multiple Sclerosis - Relapsing RemittingGermany
-
University Hospital, LilleCompleted
-
Centre Paul StraussNot yet recruiting
-
University of Michigan Rogel Cancer CenterTerminated